Clinical Trials Browser

Phase 2 × Extensive Stage Small Cell Lung Carcinoma × Immunoglobulin G × Clear all

NCT03402880 2018-10-10

ALCMI-005: Pembrolizumab and Epacadostat in Treating Patients With Extensive Stage Small Cell Lung Cancer

Phase 2 Withdrawn

Extensive Stage Small Cell Lung Carcinoma